½º¸¶Æ® Àν¶¸° Ææ ½ÃÀå : À¯Çüº°, »ç¿ë¼ºº°, ÀûÀÀÁõº°, Ä¿³ØÆ¼ºñƼº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Smart Insulin Pens Market Report by Type, Usability, Indication, Connectivity, End User, and Region 2025-2033
»óǰÄÚµå : 1702007
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 147 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,154,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,539,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,925,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½º¸¶Æ® Àν¶¸° Ææ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 1¾ï 4,480¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ÀÌ ½ÃÀåÀÌ 2033³â±îÁö 3¾ï 3,050¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â 9.6%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

½º¸¶Æ® Àν¶¸° ÆæÀº ´ç´¢º´ ȯÀÚÀÇ Àν¶¸° Åõ¿©¸¦ È¿À²ÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ´Â ½º¸¶Æ®Æù ¾ÛÀÌ Å¾ÀçµÈ Àç»ç¿ë °¡´ÉÇÑ ÁÖ»ç±â ÆæÀÔ´Ï´Ù. ±âÁ¸ Àν¶¸°¿¡ ºñÇØ °¡°ÝÀÌ Àú·ÅÇÏ°í »ç¿ëÇϱ⠽¬¿ì¸ç, À¯¿ëÇÑ ¾Ë¸², °æ°í, º¸°í¼­¸¦ Á¦°øÇÕ´Ï´Ù. Ç÷´ç, ź¼öÈ­¹°·®, ½Ä»ç·®, Ȱ¼º Àν¶¸° Åõ¿©·®À» °è»êÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, Àν¶¸° À¯È¿±â°£ ¸¸·á ¹× ¿Âµµ ¹üÀ§ Ãʰú¸¦ ¾Ë·ÁÁÖ¾î Àû½Ã¿¡ īƮ¸®Áö¸¦ ±³Ã¼ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ±× °á°ú, ½º¸¶Æ® Àν¶¸° ÆæÀº Àü ¼¼°è º´¿ø, Áø·á¼Ò, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ÀçÅà ¿ä¾ç¿ø µî¿¡¼­ Æø³Ð°Ô Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù.

½º¸¶Æ® Àν¶¸° Ææ ½ÃÀå µ¿Çâ :

ÇöÀç, ½º¸¶Æ® Àν¶¸° ÆæÀÇ ÀåÁ¡ÀÎ Á¤È®ÇÑ ¹Ý¿ë·® Åõ¿©, º¹¿ë·® ¹× º¹¿ë·® ´©¶ô ¹æÁö, º¹¿ë ½Ã°£ ¹× Ƚ¼ö ÃßÀû µî¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀåÀ» ÁÖµµÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß Çϳª°¡ µÇ¾ú½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ Àü ¼¼°èÀûÀ¸·Î ºñ¸¸°ú ³ë·É Àα¸ Áõ°¡·Î ÀÎÇØ ´ç´¢º´ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ±Þ¼ºÀåÇÏ´Â ÇコÄÉ¾î »ê¾÷°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ȯÀÚ¿¡°Ô Áö´ÉÇü Áֻ縦 Á¦°øÇÏ´Â ¸Þ¸ð¸® ¹× ŸÀÌ¹Ö ±â´ÉÀ» °®Ãá ½º¸¶Æ® Àν¶¸° ÆæÀ» µµÀÔÇϱâ À§ÇØ ¿¬±¸ °³¹ß(R&D) Ȱµ¿¿¡ ±¤¹üÀ§ÇÏ°Ô ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºí·çÅõ½º ¿¬°á ½º¸¶Æ® Àν¶¸° ÆæÀÇ °³¹ß¿¡µµ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¸´Ù Æí¾ÈÇϰí, Æí¸®Çϸç, °³ÀÎ ¸ÂÃãÇü Ä¡·á°¡ °¡´ÉÇϱ⠶§¹®¿¡ ÀçÅà ġ·áÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¹Ù´Ã »ç¿ë, Ãë±Þ, ºÐÇØ ¶Ç´Â Æó±â Áß ¹Ù´Ã¿¡ Âñ¸®´Â »ç°í°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹Ù´ÃÀ» »ç¿ëÇÏÁö ¾Ê´Â Àν¶¸° Àü´Þ ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ½º¸¶Æ® Àν¶¸° Ææ ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦7Àå ½ÃÀå ºÐ¼® : »ç¿ë¼ºº°

Á¦8Àå ½ÃÀå ºÐ¼® : ÀûÀÀÁõº°

Á¦9Àå ½ÃÀå ºÐ¼® : Ä¿³ØÆ¼ºñƼº°

Á¦10Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦12Àå SWOT ºÐ¼®

Á¦13Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦14Àå PorterÀÇ Five Forces ºÐ¼®

Á¦15Àå °¡°Ý ºÐ¼®

Á¦16Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global smart insulin pens market size reached USD 144.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 330.5 Million by 2033, exhibiting a growth rate (CAGR) of 9.6% during 2025-2033.

A smart insulin pen is a reusable injector pen with a smartphone app that facilitates patients with diabetes in managing their insulin delivery efficiently. It is more affordable, easy to use, and provides helpful reminders, alerts, and reports compared to conventional insulin. It helps calculate doses of the blood sugar level, carbohydrate amounts, meal size, and active insulin. In addition, it notifies the expiration date or exceeding the temperature range of insulin to replace the cartridge timely. As a result, smart insulin pen finds extensive applications in hospitals, clinics, ambulatory surgical centers, and home care units across the globe.

Smart Insulin Pens Market Trends:

At present, the growing awareness among the masses about the benefits of smart insulin pens, such as delivering accurate half-unit doses, preventing skipped or missed doses, and tracking time and number of doses, represents one of the key factors driving the market. Besides this, there is a rise in the prevalence of diabetes due to the increasing obesity and geriatric population across the globe. This, along with the burgeoning healthcare industry, is strengthening the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce smart insulin pens with memory and timing function that provides intelligent injection for patients. They are also focusing on developing Bluetooth-connected smart insulin pens. Moreover, there is an increase in the adoption of home treatment as it is more comfortable, convenient, and personalized. This, coupled with the escalating demand for needle-free insulin delivery devices due to the rising needle stick injuries while using, handling, disassembling, or disposing of needles, is bolstering the growth of the market.

Key Market Segmentation:

Breakup by Type:

Breakup by Usability:

Breakup by Indication:

Breakup by Connectivity:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bigfoot Biomedical Inc., Digital Medics Pty Ltd., Emperra GmbH E-Health Technologies, Jiangsu Delfu Medical Device Co. Ltd., Medtronic plc, Novo Nordisk A/S, pendiq GmbH and Ypsomed AG.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Smart Insulin Pens Market

6 Market Breakup by Type

7 Market Breakup by Usability

8 Market Breakup by Indication

9 Market Breakup by Connectivity

10 Market Breakup by End User

11 Market Breakup by Region

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Analysis

16 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â